Cargando…
Intercepting Premalignant, Preinvasive Breast Lesions Through Vaccination
Breast cancer (BC) prevention remains the ultimate cost-effective method to reduce the global burden of invasive breast cancer (IBC). To date, surgery and chemoprevention remain the main risk-reducing modalities for those with hereditary cancer syndromes, as well as high-risk non-hereditary breast l...
Autores principales: | Zachariah, Nadia Nocera, Basu, Amrita, Gautam, Namrata, Ramamoorthi, Ganesan, Kodumudi, Krithika N., Kumar, Nagi B., Loftus, Loretta, Czerniecki, Brian J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652247/ https://www.ncbi.nlm.nih.gov/pubmed/34899753 http://dx.doi.org/10.3389/fimmu.2021.786286 |
Ejemplares similares
-
Differentiation and Regulation of T(H) Cells: A Balancing Act for Cancer Immunotherapy
por: Basu, Amrita, et al.
Publicado: (2021) -
Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response
por: Kodumudi, Krithika N., et al.
Publicado: (2019) -
Intraductal Proliferative Lesions of the Breast—Terminology and Biology Matter: Premalignant Lesions or Preinvasive Cancer?
por: Costarelli, Leopoldo, et al.
Publicado: (2012) -
Current State of Cell Therapies for Breast Cancer
por: Gautam, Namrata, et al.
Publicado: (2022) -
Intratumoral delivery of dendritic cells plus anti-HER2 therapy triggers both robust systemic antitumor immunity and complete regression in HER2 mammary carcinoma
por: Ramamoorthi, Ganesan, et al.
Publicado: (2022)